✦ LIBER ✦

Combined Treatment with Angiotensin II Receptor Blocker and Arg389-Variant in Beta1-adrenergic Receptor for Introducing Carvedilol in Patients with Heart Failure

✍ Scribed by Atsushi Iwata; Shin-Ichiro Miura; Hiroaki Nishikawa; Akira Kawamura; Yoshino Matsuo; Hideto Sako; Hideya Niimura; Kunihiro Matsuo; Keijiro Saku

Book ID: 119213515
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 54 KB
Volume: 11
Category: Article
ISSN: 1532-8414
DOI: 10.1016/j.cardfail.2005.08.254

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Review finds combining angiotensin recep

Review finds combining angiotensin receptor blockers with ACE inhibitors in heart failure may only benefit people with contraindications to β blockers: Abstracted from: Dimopoulos K, Salukhe TV, Coats AJ, et al. Meta-analyses of mortality and morbidity effects of an angiotensin receptor blocker in patients with chronic heart failure already receiving an ACE inhibitor (alone or with a beta-blocker). Int J Cardiol 2004; 93(2–3): 105–11.

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 126 KB

A Single-Center, Open-Label, Randomized,

A Single-Center, Open-Label, Randomized, Parallel-Group Study Assessing the Differences Between an Angiotensin II Receptor Antagonist and an Angiotensin-Converting Enzyme Inhibitor in Hypertensive Patients with Congestive Heart Failure: The Research for Efficacy of Angiotensin II Receptor Antagonist in Hypertensive Patients with Congestive Heart Failure Study

✍ Nobuo Totsuka; Nobuhisa Awata; Katsuhito Takahashi; Hisako Yamamura; Junko Nakam 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 110 KB